# Minimum Effective Volume of 0.375% Bupivacaine in Interscalene Brachial Plexus Block

> **NCT01667315** · PHASE2 · UNKNOWN · sponsor: **Federal University of São Paulo** · enrollment: 33 (estimated)

## Conditions studied

- Shoulder Surgery

## Interventions

- **DRUG:** Bupivacaine 0,375%

## Key facts

- **NCT ID:** NCT01667315
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2013-01
- **Final completion:** 2013-09
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2012-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01667315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01667315, "Minimum Effective Volume of 0.375% Bupivacaine in Interscalene Brachial Plexus Block". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01667315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*